Skip to main content

Our Commitment to Environmental, Social & Governance Practices

Foundation Medicine is committed to reducing our overall environmental impact, investing in programs that bring equity and inclusivity to our patients and employees, and continuing to lead with ethical business practices across the organization.

Our Headquarters

We are focused on achieving Leadership in Energy and Environmental Design (LEED) accreditation for our new buildings and are committed to responsible sourcing of utilities.

Lab Waste

In 2022, we were able to minimize our waste stream, with more than 96% of laboratory waste in the U.S. diverted from landfills and treated via recycling and other reclamation technologies.


Sustain is our network of employees who are passionate about sustainability and working towards making Foundation Medicine a leading sustainable business.

Diversity, Equity & Inclusion

At Foundation Medicine, we believe that transforming cancer care requires a company culture where diversity, equity and inclusion (DE&I) is prioritized. Foundation Medicine’s inaugural DE&I report spotlights our work to evolve forward-looking and integrated DE&I initiatives and our commitment to eliminating healthcare disparities, with a focus on our efforts in 2021. The report highlights our workforce diversity numbers and shares the voices of our employees and executives. From our research to our collaborations, from the lab to our advocacy efforts, our internal commitment to DE&I is as important as our external commitment to our partners, physicians, and patients.

View Our DE&I Report

Employee Resource Networks

Through our employee resource networks (ERNs), we are working together at all levels of the organization to create sense of belonging, foster an inclusive environment, and increase equity especially in underrepresented groups. Read more about our ERNs

Supplier Diversity Program

We strategically strive to utilize an array of small and diverse suppliers to drive a competitive advantage. Through the use of these small and diverse suppliers, Foundation Medicine can align and expand to drive innovation and collaboration by building a robust network to strategically sourced goods and services. Read more about our Supplier Diversity Program

Making Cancer Care More Equitable with Diagnostics

We believe all patients living with advanced cancer should have access to genomic profiling and are committed to working across the oncology community to close existing disparities in care. Read more about our commitment to broadening inclusive access to diagnostics



Our success is driven by building a trusted and ethical corporation to serve our customers, advocates, and patients in communities around the world. To achieve our goal, we must hold ourselves to the highest ethical standards.


Our Code of Conduct is designed to support our efforts to conduct ourselves with integrity, which is essential to realizing our vision to transform cancer care and make molecular profiling indispensable to cancer care and research. Each of us has a responsibility to comply with applicable laws, our Code of Conduct, and our company policies and procedures. We all have an obligation to discuss concerns and report suspected or actual acts of noncompliance.

Risk Management

Our risk management program helps us raise awareness of our business risks, instills confidence in our strategic objectives and ensures that we will continue to be able to serve patients and customers.

Chief Financial Officer Rita Kale on Our Commitment to ESG

Join Us

We know what’s next because, at Foundation Medicine, we’re the ones creating it.

View Careers